These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20704608)

  • 1. High-dose unfractionated heparin therapy in a pregnant patient with antiphospolipid syndrome: a case report.
    Ogishima H; Ito S; Tsutsumi A; Sugihara M; Goto D; Matsumoto I; Obata-Yasuoka M; Hamada H; Yoshikawa H; Takahashi H; Murashima A; Sumida T
    Int J Rheum Dis; 2010 Aug; 13(3):e32-5. PubMed ID: 20704608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
    Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
    Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
    Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
    Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome in women with antiphospholipid syndrome on low-dose aspirin and heparin: a retrospective study.
    Naru T; Khan RS; Ali R
    East Mediterr Health J; 2010 Mar; 16(3):308-12. PubMed ID: 20795446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for managing heparin therapy in patients with antiphospholipid antibody syndrome.
    Mehta TP; Smythe MA; Mattson JC
    Pharmacotherapy; 2011 Dec; 31(12):1221-31. PubMed ID: 22122183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy.
    Clark NP; Delate T; Cleary SJ; Witt DM
    Thromb Res; 2010 May; 125(5):402-5. PubMed ID: 19699510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case reports of the use of immunoadsorption or plasma exchange in high-risk pregnancies of women with antiphospholipid syndrome.
    Bortolati M; Marson P; Chiarelli S; Tison T; Facchinetti M; Gervasi MT; De Silvestro G; Ruffatti A
    Ther Apher Dial; 2009 Apr; 13(2):157-60. PubMed ID: 19379156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed cutaneous reactions to heparin in antiphospholipid syndrome during pregnancy.
    Kim J; Smith KJ; Toner C; Skelton H
    Int J Dermatol; 2004 Apr; 43(4):252-60. PubMed ID: 15090006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
    Pauzner R; Dulitzki M; Langevitz P; Livneh A; Kenett R; Many A
    Thromb Haemost; 2001 Dec; 86(6):1379-84. PubMed ID: 11776303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of low-molecular-weight heparin during pregnancy and delivery in case of reproductive failure due to antiphospholipid syndrome].
    Karag'ozova Zh; Chernev T; Iankova Z; Baleva M; Dimitrov A
    Akush Ginekol (Sofiia); 2000; 39(3):48-51. PubMed ID: 11187998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pregnancy in primary antiphospholipid syndrome. Proposal for a common management protocol].
    el Kouri D; Winer N; Sagot P; Hamidou M; Boog G; Barrier J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(8):828-31. PubMed ID: 9026512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.
    Branch DW; Silver RM; Blackwell JL; Reading JC; Scott JR
    Obstet Gynecol; 1992 Oct; 80(4):614-20. PubMed ID: 1407882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy.
    Ensom MH; Stephenson MD
    J Soc Gynecol Investig; 2004 Sep; 11(6):377-83. PubMed ID: 15350250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful pregnancy outcome with combination therapy in women with the antiphospholipid antibody syndrome.
    Menashe Y; Ben-Baruch G; Greenspoon JS; Carp HJ; Rosen DJ; Mashiach S; Many A
    J Reprod Med; 1993 Aug; 38(8):625-9. PubMed ID: 8410869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful high-dose low-molecular-weight heparin thromboprophylaxis in pregnant women with antiphospholipid syndrome].
    Boda Z; Schlammadinger A; László P; Lakos G; Kerényi A; Pfliegler G; Rázsó K; Pósán E
    Orv Hetil; 2003 Jun; 144(23):1131-4. PubMed ID: 12858645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The APTT response of pregnant plasma to unfractionated heparin.
    Chunilal SD; Young E; Johnston MA; Robertson C; Naguit I; Stevens P; Galashan D; Oskamp ML; Brennan B; Ginsberg JS
    Thromb Haemost; 2002 Jan; 87(1):92-7. PubMed ID: 11848463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome.
    Cohen H
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():44. PubMed ID: 8992939
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of antiphospholipid syndrome in pregnancy.
    Cowchock S
    Lupus; 1998; 7 Suppl 2():S95-7. PubMed ID: 9814682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study.
    Heilmann L; Schorch M; Hahn T; Adasz G; Schilberz K; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2008 Nov; 34(8):794-802. PubMed ID: 19214917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of 75 pregnancies in patients with antiphospholipid syndrome.
    Huong DL; Wechsler B; Bletry O; Vauthier-Brouzes D; Lefebvre G; Piette JC
    J Rheumatol; 2001 Sep; 28(9):2025-30. PubMed ID: 11550970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.